APLN and cutaneous melanoma: According to the Gene Expression Profiling Interactive Analysis 2 (GEPIA2) database, patients with high apelin expression levels (n = 229) have significantly impaired survival outcomes than those with low apelin-expressing tumors (n = 229; p = 0.038) in the case of patients with skin cutaneous melanoma (Supp Fig. 3A)54.